Article Details

Faruqi & Faruqi Reminds Moderna Investors of the Pending Class Action Lawsuit with a ...

Retrieved on: 2024-10-07 16:38:54

Tags for this article:

Click the tags to see associated articles and topics

Faruqi & Faruqi Reminds Moderna Investors of the Pending Class Action Lawsuit with a .... View article details on hiswai:

Summary

The article discusses a securities class action against Moderna due to misleading statements about the efficacy of their RSV vaccine, mRNA-1345, affecting stock values. This relates to the tags on vaccines, medical research, and Moderna, particularly under the broader context of mRNA technology used in COVID-19 vaccines.

Article found on: markets.businessinsider.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up